Channelopathies: Ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system

Neuromuscular Disorders

Volumn 7, Issue 4, 1997, Pages 250-255

  Ptáček, Louis J ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Channelopathy; Ion channel disorder; Nervous system; Paroxysmal disorder

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN; SODIUM CHANNEL; SODIUM ION;

ARTICLE; ATAXIA; DYSKINESIA; EPILEPSY; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE CELL; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; LONG QT SYNDROME; MIGRAINE; MOUSE; MUSCLE CELL; MUSCLE DISEASE; NERVE CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; REFLEX EPILEPSY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; THOMSEN DISEASE;

ARRHYTHMIA; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; ION CHANNELS; MOVEMENT DISORDERS; MUTATION; MYOTONIA; PARALYSIS; PERIODICITY;

EID: 0343488504     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00046-1     Document Type: Article

References (56)

1. Koenig M, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
2. Ptáček LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482-489.
3. Ptáček LJ, George AL, Griggs RC, Tawil R, Kallen RG, Barchi RL, Robertson M, Leppert MF. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-1027.
4. + channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 1991;354:387-389.
5. McClatchey AI, et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell 1992;68:769-774.
6. Ptáček LJ, et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 1992;8:891-897.
7. Cannon SC, Strittmatter SM. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 1993;10:317-326.
8. + channel mutation causing hyperkalemic periodic paralysis. Neuron 1993;10:667-678.
9. Chahine M, et al. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron 1994;12:281-294.
10. Yang N, et al. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro. Proc Natl Acad Sci USA 1994;91:12785-12789.
11. + channel by the V1589M mutation. J Physiol Lond 1994;478(3):395-402.
12. Ptáček LJ, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-868.
13. Jurkat Rott K, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994;3:1415-1419.
14. Elbaz A, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995;56:374-380.
15. Fouad G, et al. Genotype-phenotype correlations of DHP receptor alpha-1 gene mutations causing hypokalemic periodic paralysis. Neuromuscular Disorders 1997 (in press).
16. Abdalla JA, et al. Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35. Am J Hum Genet 1992;51:579-584.
17. Koch MC, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257:797-800.
18. George AL Jr, Crackower MA, Abdalla JA, Hudson AJ, Ebers GC. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet 1993;3:305-310.
19. Heine R, et al. Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum Mol Genet 1994;3:1123-1128.
20. Gronemeier M, et al. Nonsense and missense mutations in the muscular chloride channel gene Clc-1 of myotonic mice. J Biol Chem 1994;269:5963-5967.
21. Zhang J, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology 1996 (in press).
22. Pusch M, Steinmeyer K, Koch MC, Jentsch TJ. Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel. Neuron 1995;15:1455-1463.
23. Fahlke C, Rosenbohm A, Mitrovic N, George AL Jr, Rudel R. Mechanism of voltage-dependent gating in skeletal muscle chloride channels. Biophys J 1996;71:695-706.
24. Fahlke C, Rudel R, Mitrovic N, Zhou M, George AL Jr. An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels. Neuron 1995;15:463-472.
25. Browne DL, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1 (see comments). Nat Genet 1994;8:136-140.
26. Shiang R, et al. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 1993;5:351-358.
27. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96.
28. Commission on the Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
29. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-579.
30. Tawil R, et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features (see comments). Ann Neurol 1994;35:326-330.
31. Goodenough D, Fariello R, Annis B, Chun R. Familial and acquired paroxysmal dyskinesias. Arch Neurol 1978;35:827-831.
32. Fahn S. The Paroxysmal Dyskinesias. Oxford: Butterworth-Heinemann, 1994;310-345.
33. Gowers W. Epilepsy and Other Chronic Convulsive Diseases. Their Causes, Symptoms, And Treatment (reprint of 1885 edn.). New York: Dover, 1964;75-76.
34. Spiller W. Subcortical epilepsy. Brain 1927;50:171-187.
35. Tibbles J, Barnes S. Paroxysmal dystonic choreoathetosis of Mount and Reback. Pediatrics 1980;65:149-151.
36. Burger L, Lopez R, Elliott F. Tonic seizures induced by movement. Neurology 1972;22:656-659.
37. Fukuyama S, Okada R. Hereditary kinesigenic reflex epilepsy: report of five families of peculiar seizures induced by sudden movements. Adv Neurol Sci 1967;11:168-197.
38. Fouad GT, Servidei S, Durcan S, Bertini E, Ptáček LJ. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 1996;59:135-139.
39. Hirata K, et al. Paroxysmal kinesigenic choreoathetosis with abnormal electroencephalogram during attacks. Epilepsia 1991;32:492-494.
40. Lombroso CT. Paroxysmal choreoathetosis: an epileptic or non-epileptic disorder? Ital J Neurol Sci 1995;16:271-277.
41. Lugaresi E, Cirigonotta F. Hypnogenic paroxysmal dystonia: epileptic seizures or a new syndrome? Sleep 1981;14:129-138.
42. Tinuper P, et al. Nocturnal paroxysmal dystonia with short-lasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures. Epilepsia 1990;31:549-556.
43. Oguni M, Oguni H, Kozasa M, Fukuyama Y. A case with nocturnal paroxysmal unilateral dystonia and interictal right frontal epileptic EEG focus: a lateralized variant of nocturnal paroxysmal dystonia? Brain Dev 1992;14:412-416.
44. Sellal F, Hirsch E. Nocturnal paroxysmal dystonia (letter; comment). Mov Disord 1993;8:252-253.
45. Meierkord H, et al. Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy? (see comments). Mov Disord 1992;7:38-42.
46. Griggs RC, Moxley RT, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978;28:1259-1264.
47. Wang Q, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811.
48. Curran ME, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
49. Wang Q, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23.
50. Steinlein OK, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995;11:201-203.
51. Kramer PL, et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p (letter). Am J Hum Genet 1995;57:182-185.
52. Vahedi K, et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p (see comments). Ann Neurol 1995;37: 289-293.
53. von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 1995;4:279-284.
54. Joutel A, et al. Genetic heterogeneity of familial hemiplegic migraine. Am J Hum Genet 1994;55:1166-1172.
55. Ophoff RA, et al. Genetic heterogeneity of familial hemiplegic migraine. Genomics 1994;22:21-26.
56. Auburger G, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probable within 2 cM between D1S443 and D1S197. Genomics 1996;31:90-94.